This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Guidance

National Institute for Health Research
NIHR's response to COVID-19.

NHS Health Research Authority
Rsearch guidance on COVID-19  from NHS Health Research Authority.

The Medicines and Healthcare products Regulatory Agency (MHRA) 
Guidance for industry covering the corona virus from MHRA.

The Federal Drugs administration 
The latest COVID-19 information from the US FDA.

The Health Research Authority (HRA) 
Guidance about COVID-19 for sponsors, sites and researchers from the HRA.

The Laboratory Animals Veterinary Association (LAVA) 
Suggested considerations for Establishments working under ASPA during COVID-19.

Clinical Guidance

COVID-19 Therapeutics Advice & Support Group (CTAG)
RCP subcommittee set up to provide interim support on use of medicines for COVID-19.

Royal College of Physicians guidance for clinical academics
Reassurance and guidance for clinical academics who are being asked, or who are requesting, to return to clinical duties to support patient care.

Interim guidance for Belgium
Interim clinical guidance for adults with suspected or confirmed COVID-19 in Belgium.

JACI In Practice
In Practice offers expedited reviews for COVID-19 related articles that are relevant to the field of clinical allergy/immunology.

American Thoracic Society guidance
Guidance from the ATS on managing the ventilation of COVID-19 patients.

Clinical guidance for intensive care and anaesthetics
Information, guidance and resources supporting the understanding and management of Coronavirus (COVID-19).

National COVID-19 Clinical Evidence Taskforce (Australia)
Supporting Australia's healthcare professionals with continually updated, evidence-based clinical guidelines.